Several studies in DM-2 subjects have explored incretin release after consumption of oral nutritional supplements with sucromalt or isomaltulose [18,35]; however, GI and GL have only been studied in healthy subjects [35,36] and not in diabetic patients. The gene discussed is GCG; the disease is myotonic dystrophy type 2.